Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Aubagio

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,538Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche's Experimental MS Drug Hits Main Goal in One of Two Trial
    Roche's Experimental MS Drug Hits Main Goal in One of Two Trial

    09 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251109262712/en/Genentechs-Fenebrutinib-Shows-Unprecedented-Positive-Phase-III-Results-as-the-Potential-First-and-Only-BTK-Inhibitor-in-Both-Relapsing-and-Primary-Progressive-Multiple-Sclerosis

    BUSINESSWIRE
    09 Nov 2025
    Share Share
    Enforcement Report - Week of April 16, 2025
    Enforcement Report - Week of April 16, 2025

    16 Apr 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-16-2025-39741.pdf

    FDA
    16 Apr 2025
    Share Share
    Concord Biotech approved by US FDA to market Teriflunomide
    Concord Biotech approved by US FDA to market Teriflunomide

    07 Apr 2025

    // BUSINESS STD

    https://www.business-standard.com/markets/capital-market-news/concord-biotech-gets-us-fda-nod-for-marketing-multiple-sclerosis-drug-teriflunomide-125040900207_1.html

    BUSINESS STD
    07 Apr 2025
    Share Share
    Torrent Pharma's Generic Teriflunomide Receives Approval in the U.S.
    Torrent Pharma's Generic Teriflunomide Receives Approval in the U.S.

    04 Apr 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209697

    FDA
    04 Apr 2024
    Share Share
    Merck KGaA suffers major blow as MS drug fails in late-stage trials
    Merck KGaA suffers major blow as MS drug fails in late-stage trials

    06 Dec 2023

    // Ludwig Burger REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/merck-kgaa-says-ms-drug-fails-late-stage-trials-2023-12-05/

    Ludwig Burger REUTERS
    06 Dec 2023
    Share Share
    Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide
    Tiefenbacher Pharmaceuticals Launch Of Generic Teriflunomide

    27 Sep 2023

    // PRESS RELEASE

    https://tiefenbacher-pharmaceuticals.com/2023/09/27/launch-tiefenbacher-pharmaceuticals-generic-version-teriflunomide/

    PRESS RELEASE
    27 Sep 2023
    Share Share